QQ客服 官方微博 反馈留言

	The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-kappa B activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells
	Huang, Kai; Yang, Chao; Wang, Qi-xue; Li, Yan-sheng; Fang, Chuan; Tan, Yan-li; Wei, Jian-wei; Wang, Yun-fei; Li, Xin; Zhou, Jun-hu
刊名	CANCER LETTERS
	2017
卷号	388页码:269-280
关键词	UBXN1 NF-KB CRISPR/Cas9 EGFR/EGFRvIII Glioblastoma
DOI	10.1016/j.canlet.2016.12.011
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4593623
专题	山东大学
作者单位	Tian
推荐引用方式 GB/T 7714	Huang, Kai,Yang, Chao,Wang, Qi-xue,et al. The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-kappa B activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells[J]. CANCER LETTERS,2017,388:269-280.
APA	Huang, Kai.,Yang, Chao.,Wang, Qi-xue.,Li, Yan-sheng.,Fang, Chuan.,...&Geng D.(2017).The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-kappa B activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells.CANCER LETTERS,388,269-280.
MLA	Huang, Kai,et al."The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-kappa B activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells".CANCER LETTERS 388(2017):269-280.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。